EDAP and Telix announce collaboration on prostate cancer treatment

Go back to EDAP and Telix announce collaboration on prostate cancer treatment
EDAP TMS SA (NASDAQ: EDAP) Delayed: 4.32 --0 (-0%)
Previous Close $4.32    52 Week High $5.85 
Open $4.32    52 Week Low $2.43 
Day High $4.32    P/E N/A 
Day Low $4.32    EPS $0.00 
Volume 392